217 related articles for article (PubMed ID: 34378358)
1. Chromatin Remodeling of Colorectal Cancer Liver Metastasis is Mediated by an HGF-PU.1-DPP4 Axis.
Wang L; Wang E; Prado Balcazar J; Wu Z; Xiang K; Wang Y; Huang Q; Negrete M; Chen KY; Li W; Fu Y; Dohlman A; Mines R; Zhang L; Kobayashi Y; Chen T; Shi G; Shen JP; Kopetz S; Tata PR; Moreno V; Gersbach C; Crawford G; Hsu D; Huang E; Bu P; Shen X
Adv Sci (Weinh); 2021 Oct; 8(19):e2004673. PubMed ID: 34378358
[TBL] [Abstract][Full Text] [Related]
2. Organ-specific cholesterol metabolic aberration fuels liver metastasis of colorectal cancer.
Zhang KL; Zhu WW; Wang SH; Gao C; Pan JJ; Du ZG; Lu L; Jia HL; Dong QZ; Chen JH; Lu M; Qin LX
Theranostics; 2021; 11(13):6560-6572. PubMed ID: 33995676
[No Abstract] [Full Text] [Related]
3. A two-step, PU.1-dependent mechanism for developmentally regulated chromatin remodeling and transcription of the c-fms gene.
Krysinska H; Hoogenkamp M; Ingram R; Wilson N; Tagoh H; Laslo P; Singh H; Bonifer C
Mol Cell Biol; 2007 Feb; 27(3):878-87. PubMed ID: 17116688
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of aggressive hepatectomy for colorectal liver metastasis, evaluated from the HGF/c-Met pathway.
Matsui S; Osada S; Tomita H; Komori S; Mori R; Sanada Y; Takahashi T; Yamaguchi K; Yoshida K
Int J Oncol; 2010 Aug; 37(2):289-97. PubMed ID: 20596656
[TBL] [Abstract][Full Text] [Related]
5. Activation of c-Met in colorectal carcinoma cells leads to constitutive association of tyrosine-phosphorylated beta-catenin.
Herynk MH; Tsan R; Radinsky R; Gallick GE
Clin Exp Metastasis; 2003; 20(4):291-300. PubMed ID: 12856716
[TBL] [Abstract][Full Text] [Related]
6. FOXC2 promotes colorectal cancer metastasis by directly targeting MET.
Cui YM; Jiao HL; Ye YP; Chen CM; Wang JX; Tang N; Li TT; Lin J; Qi L; Wu P; Wang SY; He MR; Liang L; Bian XW; Liao WT; Ding YQ
Oncogene; 2015 Aug; 34(33):4379-90. PubMed ID: 25381815
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation and chromatin modifiers in colorectal cancer.
Vymetalkova V; Vodicka P; Vodenkova S; Alonso S; Schneider-Stock R
Mol Aspects Med; 2019 Oct; 69():73-92. PubMed ID: 31028771
[TBL] [Abstract][Full Text] [Related]
8. Chromatin accessibility changes are associated with enhanced growth and liver metastasis capacity of acid-adapted colorectal cancer cells.
Zhou ZH; Wang QL; Mao LH; Li XQ; Liu P; Song JW; Liu X; Xu F; Lei J; He S
Cell Cycle; 2019 Feb; 18(4):511-522. PubMed ID: 30712429
[TBL] [Abstract][Full Text] [Related]
9. Expression of HGF and Met in human tissues of colorectal cancers: biological and clinical implications for synchronous liver metastasis.
Sun YL; Liu WD; Ma GY; Gao DW; Jiang YZ; Liu Q; Du JJ
Int J Med Sci; 2013; 10(5):548-59. PubMed ID: 23532910
[TBL] [Abstract][Full Text] [Related]
10. Histone H4 HDAC activity is necessary for expression of the PU.1 gene.
Laribee RN; Klemsz MJ
Biochim Biophys Acta; 2005 Sep; 1730(3):226-34. PubMed ID: 16139904
[TBL] [Abstract][Full Text] [Related]
11. Alternative Activation of Macrophages Is Accompanied by Chromatin Remodeling Associated with Lineage-Dependent DNA Shape Features Flanking PU.1 Motifs.
Tang MS; Miraldi ER; Girgis NM; Bonneau RA; Loke P
J Immunol; 2020 Aug; 205(4):1070-1083. PubMed ID: 32661179
[TBL] [Abstract][Full Text] [Related]
12. C/EBPα and PU.1 are involved in distinct differentiation responses of acute promyelocytic leukemia HL-60 and NB4 cells via chromatin remodeling.
Savickiene J; Treigyte G; Vistartaite G; Tunaitis V; Magnusson KE; Navakauskiene R
Differentiation; 2011 Jan; 81(1):57-67. PubMed ID: 20864248
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic upregulation of HGF and c-Met drives metastasis in hepatocellular carcinoma.
Ogunwobi OO; Puszyk W; Dong HJ; Liu C
PLoS One; 2013; 8(5):e63765. PubMed ID: 23723997
[TBL] [Abstract][Full Text] [Related]
14. Role of HGF/c-Met in the treatment of colorectal cancer with liver metastasis.
Yao JF; Li XJ; Yan LK; He S; Zheng JB; Wang XR; Zhou PH; Zhang L; Wei GB; Sun XJ
J Biochem Mol Toxicol; 2019 Jun; 33(6):e22316. PubMed ID: 30897285
[TBL] [Abstract][Full Text] [Related]
15. Role of PU.1 in MHC class II expression through transcriptional regulation of class II transactivator pI in dendritic cells.
Kitamura N; Yokoyama H; Yashiro T; Nakano N; Nishiyama M; Kanada S; Fukai T; Hara M; Ikeda S; Ogawa H; Okumura K; Nishiyama C
J Allergy Clin Immunol; 2012 Mar; 129(3):814-824.e6. PubMed ID: 22112519
[TBL] [Abstract][Full Text] [Related]
16. PU.1 Suppresses Th2 Cytokine Expression via Silencing of GATA3 Transcription in Dendritic Cells.
Yashiro T; Kubo M; Ogawa H; Okumura K; Nishiyama C
PLoS One; 2015; 10(9):e0137699. PubMed ID: 26361334
[TBL] [Abstract][Full Text] [Related]
17. Mutant KRAS promotes liver metastasis of colorectal cancer, in part, by upregulating the MEK-Sp1-DNMT1-miR-137-YB-1-IGF-IR signaling pathway.
Chu PC; Lin PC; Wu HY; Lin KT; Wu C; Bekaii-Saab T; Lin YJ; Lee CT; Lee JC; Chen CS
Oncogene; 2018 Jun; 37(25):3440-3455. PubMed ID: 29559746
[TBL] [Abstract][Full Text] [Related]
18. Effect of hepatocyte growth factor on progression of liver metastasis in colorectal cancer.
Osada S; Matsui S; Komori S; Yamada J; Sanada Y; Ihawa A; Tanaka Y; Tokuyama Y; Okumura N; Nonaka K; Hosono Y; Takahashi T; Yamaguchi K; Yoshida K
Hepatogastroenterology; 2010; 57(97):76-80. PubMed ID: 20422876
[TBL] [Abstract][Full Text] [Related]
19. PU.1 Is Identified as a Novel Metastasis Suppressor in Hepatocellular Carcinoma Regulating the miR-615-5p/IGF2 Axis.
Song LJ; Zhang WJ; Chang ZW; Pan YF; Zong H; Fan QX; Wang LX
Asian Pac J Cancer Prev; 2015; 16(9):3667-71. PubMed ID: 25987019
[TBL] [Abstract][Full Text] [Related]
20. Gankyrin activates IL-8 to promote hepatic metastasis of colorectal cancer.
Bai Z; Tai Y; Li W; Zhen C; Gu W; Jian Z; Wang Q; Lin JE; Zhao Q; Gong W; Liang B; Wang C; Zhou T
Cancer Res; 2013 Jul; 73(14):4548-58. PubMed ID: 23576566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]